发明授权
- 专利标题： GSK-3β inhibitor
- 专利标题（中）： GSK-3β抑制剂
-
申请号： US12309906申请日： 2007-08-02
-
公开(公告)号： US08492378B2公开(公告)日： 2013-07-23
- 发明人: Fumio Itoh , Jun Kunitomo , Hiromi Kobayashi , Eiji Kimura , Morihisa Saitoh , Tomohiro Kawamoto , Hiroki Iwashita , Katsuhito Murase
- 申请人： Fumio Itoh , Jun Kunitomo , Hiromi Kobayashi , Eiji Kimura , Morihisa Saitoh , Tomohiro Kawamoto , Hiroki Iwashita , Katsuhito Murase
- 申请人地址： JP Osaka
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka
- 代理机构： Wenderoth, Lind & Ponack, L.L.P.
- 优先权： JP2006-212642 20060803
- 国际申请： PCT/JP2007/065203 WO 20070802
- 国际公布： WO2008/016123 WO 20080207
- 主分类号： A61K31/535
- IPC分类号： A61K31/535
摘要：
For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.
公开/授权文献
- US20100069381A1 GSK-3BETAINHIBITOR 公开/授权日：2010-03-18
信息查询
